iVEAcare Raises $27.5M for Expansion and Development
iVEAcare Raises $27.5M in Series A Funding
iVEAcare's Series A Funding
Key Highlights:
- Series A Funding: Raised $27.5 million in Series A funding.
- Investors: Led by Vensana Capital, with participation from Treo Ventures, Hatteras Venture Partners, and an undisclosed strategic partner.
- Expansion and Development: Funds will be used to expand operations and development efforts.
iVEAcare's Target Market
- Target Market: Focus on patients suffering from chronic diseases with unmet clinical needs.
- Medical Device Industry: Collaborate with healthcare providers and medical institutions to provide innovative neuromodulation therapy solutions.
- Chronic Disease Treatment: Address the needs of large patient populations by developing technology platforms for chronic disease treatment.
What iVEAcare Needs to Buy
- Research and Development Partnerships: Collaborate with research institutions and medical device accelerators for further development of their neuromodulation therapy.
- Manufacturing and Supply Chain Solutions: Partner with manufacturers to produce and distribute their medical devices.
- Marketing and Sales Support: Engage with marketing agencies and sales experts to effectively reach healthcare providers and expand market presence.